Trinity Capital Inc. Provides Up to $50 Million in Growth Funding to Nalu Medical, Supporting Continued Commercial Momentum

Core Insights - Trinity Capital Inc. has committed up to $50 million in growth funding to Nalu Medical, Inc., a company focused on neurostimulation solutions for chronic neuropathic pain [1][3] Company Overview - Trinity Capital Inc. is an alternative asset manager that aims to deliver consistent returns through private credit markets, with a focus on growth-oriented companies [4] - Nalu Medical, Inc. is a medical technology company based in Carlsbad, California, specializing in minimally invasive solutions for chronic neuropathic pain [5] Product and Technology - Nalu's Neurostimulation System utilizes a proprietary implantable pulse generator (IPG) to modulate pain signals before they reach the brain, featuring a small, battery-free device controlled via smartphone [2][5] - The system has received FDA clearance for implantation and expanded labeling for whole-body MRI-conditional use [2] Strategic Partnership - Trinity Capital expresses confidence in Nalu's leadership in peripheral nerve stimulation (PNS) and its innovative technology, which is reshaping pain management [3] - Nalu's CEO highlights the importance of this financial partnership for the commercial expansion of their next-generation Therapy Disc and the publication of significant long-term real-world data supporting their device's efficacy [3]